Phytoantioxidants and Nanotherapeutics
1. Edition October 2022
576 Pages, Hardcover
Wiley & Sons Ltd
The book comprehensively reviews the medicinal importance of phytomedicine-derived antioxidants with their development into nano-sized drug delivery systems for a wide range of diseases such as cancer, inflammation, diabetes, viral and parasitic infections, nervous system disorders, cardiovascular disorders, and neurological diseases. The chapters cover phytomedicine-derived bioactive compounds as antioxidants and their role in oxidative stress induced human diseases. In addition, they discuss herbs, plant extracts, and other dietary elements as sources of natural antioxidants and their potential medicinal benefits. Biochemical and therapeutic targets of nanodrugs are featured along with nanostructure toxicity . Finally, this book highlights the challenges and regulatory issues involved with nanophytotherapeutics.
Price: 209,00 €
Price incl. VAT, excl. Shipping
Phytoantioxidants and Nanotherapeutics
Discover the medicinal importance of antioxidant herbal medicines, phytochemicals, and nanodelivery systems for a wide range of diseases
Phytomedicine has been--and continues to be--central to many cultures and societies due to its low toxicity, low cost, accessibility, and efficacy in treating difficult diseases. In fact, many plant-derived bioactive natural products serve as potential sources of drug leads or therapeutic agents in the treatment of a wide range of human diseases. When combined with nanotechnology, phytomedicine has the potential to affect and impact a tissue-specific site, which can reduce drug dosage and side effects while improving activity.
Phytoantioxidants and Nanotherapeutics offers a comprehensive look at the significant role that phytomedicine-derived antioxidants play on the field of medicine, particularly when combined with the nanotechnology-derived drug delivery systems. The book thoroughly covers the herbs, plant extracts, and other dietary elements that may be used as sources of natural antioxidants and similarly highlights the use of phytomedicine- derived bioactive compounds including plant polyphenols and flavonoids to reducing the impact of oxidative stress induced human diseases. The text also demonstrates the biochemical and therapeutic targets of nanodrugs and discusses nanostructure toxicity, while emphasizing the challenges and regulatory issues involved with nanophytotherapeutics.
Phytoantioxidants and Nanotherapeutics readers will also find:
* A helpful bridge between the cutting-edge field of nanotechnology delivery and phytotherapeutics
* The potential role of bioactive phytochemicals, particularly polyphenolic compounds and flavonoids, in oxidative stress-induced diseases
* Description of the latest developments on nanotherapeutics of phytoantioxidants for the treatment of certain chronic human diseases, such as cancer, inflammations, diabetes, viral, bacterial and parasitic infections, nervous system disorders, cardiovascular disorders, and neurological diseases.
Phytoantioxidants and Nanotherapeutics is a useful reference for drug manufacturers and drug developers, formulation scientists, biomedical scientists, medicinal chemists, phytochemists, healthcare providers, and academics and researchers.
Chapter 2 - Phytomedicines as sources of natural antioxidants
Chapter 3 - Herbs, spices and dietary constituents as sources of phytoantioxidants
Chapter 4 - Phytoantioxidants and their role in cellular oxidative stress
Chapter 5 - Bioactive flavonoids as phytoantioxidants
Chapter 6 - Nanoparticulate delivery systems for phytoconstituents
Chapter 7 - Nanodelivery of herbal- and phyto-antioxidants
Chapter 8 - Nanodelivery of antioxidant herbal extracts, spice and dietary constituents
Chapter 9 - Nanophytomedicines in disease and therapy
Chapter 10 - Biochemical and therapeutic targets for nanophytomedicines
Chapter 11 - Green approaches for synthesis of nanophytopharmaceuticals/nanophytodelivery systems
Chapter 12 - Characterization of nanophytopharmaceuticals
Chapter 13 - Toxicity of nanostructures and nanodrugs
Chapter 14 - Nanotherapeutics of Phytoantioxidants for Microbial Infections
Chapter 15 - Nanotherapeutics of phytoantioxidants for viral infections
Chapter 16 - Nanotherapeutics of phytoantioxidants for parasitic diseases and neglected tropical diseases
Chapter 17 - Nanotherapeutics of phytoantioxidants for inflammatory disorders
Chapter 18 - Nanotherapeutics of phytoantioxidants for cardiovascular diseases
Chapter 19 - Nanotherapeutics of phytoantioxidants for diabetes
Chapter 20 - Nanotherapeutics of phytoantioxidants for CNS disorders
Chapter 21 - Nanotherapeutics of phytoantioxidants for aging and neurological disorders
Chapter 22 - Nanotherapeutics of phytoantioxidants for cancer
Chapter 23 - Challenges and regulatory issues of nanophytotherapeutics